GPT and hepatocellular carcinoma: In our study, the relative activity of ALT was evaluated in HCC cell lysates, revealing a significant increase in enzyme activity exclusively in the HepG2 cells following either individual or combined drug administration, with CHK1i monotherapy showing nearly a 30% increase compared to the control.